Skip to Content

G352 (Fenofibrate 160 mg)

Pill with imprint G352 is White, Capsule-shape and has been identified as Fenofibrate 160 mg. It is supplied by Global Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 160 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G352

Fenofibrate 160 mg G352
Fenofibrate 160 mg G352  Front
Fenofibrate 160 mg G352  Back
Fenofibrate 160 mg G352  Front
Fenofibrate 160 mg G352  Back
Fenofibrate 160 mg G352
Fenofibrate 160 mg G352
Fenofibrate 160 mg G352

Fenofibrate

Imprint
G352
Strength
160 mg
Color
White
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Global Pharmaceuticals
Inactive Ingredients
croscarmellose sodium, hypromelloses, magnesium stearate, microcrystalline cellulose, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), hypromellose 2910 (50 mPa.s), polyethylene glycol, polydextrose, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00115-5522 Global Pharmaceuticals
68084-0328 Amerisource Health Services
42291-0290 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "G352"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.